Innate Pharma (IPHA) Profit Margin (2005 - 2026)
Innate Pharma (IPHA) profit margin from Jun 30, 2005 to Mar 31, 2026. The current Innate Pharma (IPHA) profit margin is 1334.78%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Profit Margin
Quarterly Profit Margin
Annual Profit Margin change of Innate Pharma (IPHA)
| Year | Profit Margin | Change |
|---|---|---|
| 2025 | -1762.72% | +349.68% |
| 2024 | -392.00% | +2587.53% |
| 2023 | -14.59% | -85.52% |
| 2022 | -100.75% | -76.90% |
| 2021 | -436.09% | +375.55% |
| 2020 | -91.70% | +204.66% |
| 2019 | -30.10% | -888.42% |
| 2018 | 3.82% | -102.57% |
| 2017 | -148.27% | -758.76% |
| 2016 | 22.51% | -160.07% |
| 2015 | -37.47% | -98.26% |
| 2014 | -2159.34% | +9217.29% |
| 2013 | -23.18% | -24.82% |
| 2012 | -30.83% | -48.15% |
| 2011 | -59.45% | -81.20% |
| 2010 | -316.20% | +66.86% |
| 2009 | -189.51% | +148.57% |
| 2008 | -76.24% | +22.14% |
| 2007 | -62.42% | -35.93% |
| 2006 | -97.42% | N/A |
Comparison Innate Pharma (IPHA) profit margin with competitors
Innate Pharma (IPHA) profit margin is 1334.78%.